富马酸二甲酯与烟酸是否诱发共同HCA2介导的不良反应
本研究通过EudraVigilance数据库比较富马酸二甲酯与烟酸的自发不良反应报告,并在小鼠器官中筛查HCA2表达,发现两者在胃肠道、肝胆检查及焦虑相关ADR上存在相似性,且HCA2在胃肠道、肝脏和中枢神经系统表达,提示这些共同ADR可能由HCA2介导;而淋巴细胞减少和血糖升高则呈现差异。
要点
- 富马酸二甲酯与烟酸的胃肠道ADR相似,可能由HCA2介导。
- 两者在肝胆检查及焦虑相关ADR上也呈现相似性。
- 淋巴细胞减少仅见于富马酸二甲酯,血糖升高更常见于烟酸。
核心结论
- 两种药物共有的胃肠道ADR可能由HCA2介导,其他不共有的ADR为化合物或适应症特异性反应,可能不涉及HCA2。
研究设计与样本
- 基于EudraVigilance数据库的自发ADR报告分析,并在小鼠器官中筛查HCA2表达。
主要发现
- 在High Level Group Terms中,胃肠道体征和症状OR 0.8(0.6-1.1),肝胆检查OR 1.3(0.7-2.5),焦虑障碍和症状OR 0.9(0.3-2.2)。
- 在High Level Terms中,腹泻(排除感染性)OR 1.2(0.7-1.8),肝功能分析OR 1.3(0.7-2.6)。
- 在Preferred Terms中,腹泻OR 1.2(0.7-2.0),呕吐OR 0.9(0.4-1.7)。
- HCA2在小鼠胃肠道、肝脏和中枢神经系统表达。
- 淋巴细胞减少(n=777)仅在富马酸二甲酯报告中出现;血糖升高更常见于烟酸(OR 0.1 [0.0-0.5])。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Dimethyl fumarate and nicotinic acid activate the hydroxy-carboxylic acid receptor 2 (HCA2 ) and induce flushing. It is not known whether HCA2 mediates other adverse drug reactions (ADRs) to these two substances. This study aims to compare ADRs associated with dimethyl fumarate and nicotinic acid, and to discuss whether they are HCA2 -mediated. METHODS: We identified spontaneous reports of suspected ADRs to dimethyl fumarate and nicotinic acid in the European Adverse Drug Reaction Database (EudraVigilance). These reports were analysed at different hierarchical levels of the Medical Dictionary for Regulatory Activities (MedDRA). In addition, we screened murine organs for HCA2 expression. RESULTS: Similarities in the ADR profile of dimethyl fumarate and nicotinic acid included "gastrointestinal signs and symptoms" (odds ratio [OR] 0.8 [0.6-1.1]), "hepatobiliary investigations" (OR 1.3 [0.7-2.5]) and "anxiety disorders and symptoms" (OR 0.9 [0.3-2.2]) in High Level Group Terms; "diarrhoea (excluding infective)" (OR 1.2 [0.7-1.8]) and "liver function analyses" (OR 1.3 [0.7-2.6]) in High Level Terms; and "diarrhoea" (OR 1.2 [0.7-2.0]) and "vomiting" (OR 0.9 [0.4-1.7]) in Preferred Terms. In analogy, HCA2 was expressed in the gastrointestinal tract, liver and central nervous system (CNS) of murine organs. A discrepant ADR profile was seen for "lymphopenia" (n = 777) at the preferred term level (only reported for dimethyl fumarate) and "blood glucose increased" (more often reported for nicotinic acid; OR 0.1 [0.0-0.5]). CONCLUSION: The gastrointestinal ADRs common to both substances may be mediated by HCA2 . Other ADRs not common to both substances are compound or indication-specific reactions and likely do not involve HCA2 .
引用
- Dubrall D, Pflock R, Kosinska J, et al. Do dimethyl fumarate and nicotinic acid elicit common, potentially HCA2 -mediated adverse reactions? A combined epidemiological-experimental approach. Br J Clin Pharmacol. 2021. PMID: 33605454. doi:10.1111/bcp.14787
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。